Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?

被引：28
|
作者：
Eriksson, U [1 ]
Opravil, M [1 ]
Amann, FW [1 ]
Schaffner, A [1 ]
机构：
[1] Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland
来源：
AIDS | 1998年 / 12卷 / 15期
关键词：
D O I：
10.1097/00002030-199815000-00024
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2079 / 2080
页数：2
相关论文
共 50 条
  • [31] Mortality after myocardial infarction in HIV-infected patients who have initiated HAART
    Rasmussen, Line D.
    Gerstoft, Jan
    Kronborg, Gitte
    Larsen, Carsten S.
    Pedersen, Gitte
    Obel, Niels
    AIDS, 2007, 21 (07) : 873 - 875
  • [32] Tobacco smoking as a risk factor of active tuberculosis in HIV-infected patients
    Kulabukhova, Ekaterina
    Zimina, Vera N.
    Kravtchenko, Alexey V.
    Degtyareva, Svetlana Yu
    Beloborodova, Elena N.
    Peregudova, Alla B.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [33] Cancer in HIV-infected and in older patients. Is there a common risk factor?
    Cappellani, A.
    Cacopardo, B.
    Fiorica, F.
    Piccolo, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (09) : 1311 - 1312
  • [34] Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin
    Moreno, S
    Podzamczer, D
    Blázquez, R
    Iribarren, JA
    Ferrer, E
    Reparaz, J
    Peña, JM
    Cabrero, E
    Usán, L
    AIDS, 2001, 15 (09) : 1185 - 1187
  • [35] Efficacy of Lopinavir-Ritonavir Reduced Dose in HIV-Infected Patients
    Lattuada, Emanuela
    Lanzafame, Massimiliano
    Vento, Sandro
    AIDS PATIENT CARE AND STDS, 2011, 25 (08) : 455 - 456
  • [36] The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients
    Kiser, J. J.
    Carten, M. L.
    Aquilante, C. L.
    Anderson, P. L.
    Wolfe, P.
    King, T. M.
    Delahunty, T.
    Bushman, L. R.
    Fletcher, C. V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 265 - 272
  • [37] Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients
    Lopez Aspiroz, Elena
    Santos Buelga, Dolores
    Cabrera Figueroa, Salvador Enrique
    Valverde Merino, Maria de la Paz
    Cordero Sanchez, Miguel
    Dominguez-Gil Hurle, Alfonso
    Carracedo, Angel
    Garcia Sanchez, Maria Jose
    PERSONALIZED MEDICINE, 2014, 11 (07) : 693 - 704
  • [38] Treatment of hyperlipidemia in HIV-infected patients
    Geletko, SM
    ZuWallack, AR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (07) : 607 - 614
  • [39] Treatment of depression in HIV-infected patients
    Cazzullo, CL
    Bessone, E
    Bertrando, P
    Pedrazzoli, L
    Cusini, M
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1998, 23 (05): : 293 - 297
  • [40] Treatment of dyslipidemia in HIV-infected patients
    Sekhar, Rajagopal V.
    Balasubramanyam, Ashok
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (11) : 1845 - 1854
12345